[{"NetIncomeLoss_1_Q2_USD":-44673000.0,"RoyaltyExpense_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":7.61,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":77563000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":69600000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":66000.0,"ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_0_Q2_USD":504711000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":12078560.0,"AccruedLiabilitiesCurrentAndNoncurrent_0_Q2_USD":27181000.0,"AssetsCurrent_0_Q2_USD":396059000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":27181000.0,"CostsAndExpensesRelatedParty_2_Q2_USD":435000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":10695000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":7124000.0,"TreasuryStockShares_0_Q2_shares":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":103848980.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":103848980.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":3000.0,"SaleOfStockPricePerShare_0_Q2_USD":8.0,"TreasuryStockValue_0_Q2_USD":0.0,"OtherAccruedLiabilitiesCurrentAndNoncurrent_0_Q2_USD":4000.0,"CostsAndExpensesRelatedParty_1_Q2_USD":247000.0,"CommonStockSharesIssued_0_Q2_shares":5599240.0,"CommitmentsAndContingencies_0_Q2_USD":null,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_2_Q2_USD":-0.66,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":7.61,"AccruedProfessionalFeesCurrentAndNoncurrent_0_Q2_USD":2262000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2_Q2_shares":0.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":21054000.0,"ConvertiblePreferredStockSharesIssuedUponConversion_0_Q2_shares":84722420.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"CommonStockValue_0_Q2_USD":1000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":334832000.0,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_1_Q2_USD":-0.18,"OtherAssetsCurrent_0_Q2_USD":261000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":2159000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":392509000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":4067000.0,"Liabilities_0_Q2_USD":37905000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_Q2_shares":4194930.0,"PreferredStockSharesOutstanding_0_Q2_shares":16944484.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":12.8,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":125574.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":249769.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":1272000.0,"Assets_0_Q2_USD":397992000.0,"ShareBasedCompensation_2_Q2_USD":3929000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":4.61,"CommonStockSharesOutstanding_0_Q2_shares":5599240.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":14931630.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3342000.0,"PreferredStockLiquidationPreferenceValue_0_Q2_USD":505399000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-57311000.0,"OtherNonoperatingGainsLosses_2_Q2_USD":-6000.0,"OtherNonoperatingGainsLosses_1_Q2_USD":-5000.0,"LiabilitiesCurrent_0_Q2_USD":37897000.0,"AccountsPayableCurrent_0_Q2_USD":10716000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":277521000.0,"NonoperatingIncomeExpense_2_Q2_USD":26000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":392509000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3550000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":77563000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2_Q2_shares":1398310.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":16944484.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_2_Q2_USD":335264000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":0.0,"NetIncomeLoss_2_Q2_USD":-83373000.0,"NonoperatingIncomeExpense_1_Q2_USD":18000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-148692000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":92500.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":14931630.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":5.96,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q2_USD":6.75,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":1146000.0,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"OperatingIncomeLoss_2_Q2_USD":-83399000.0,"OperatingIncomeLoss_1_Q2_USD":-44691000.0,"InvestmentIncomeInterest_2_Q2_USD":32000.0,"InvestmentIncomeInterest_1_Q2_USD":23000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":9.26,"PreferredStockValue_0_Q2_USD":504711000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":397992000.0,"PreferredStockSharesAuthorized_0_Q2_shares":16944484.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":3929000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":3342000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":115000.0,"OperatingExpenses_2_Q2_USD":83399000.0,"OperatingExpenses_1_Q2_USD":44691000.0,"ProfitLoss_2_Q2_USD":-83373000.0,"StockholdersEquity_0_Q2_USD":-144624000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":35067000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":69204000.0,"Ticker":"ADGI","CIK":"1832038","name":"ADAGIO THERAPEUTICS, INC.","OfficialName":"Adagio Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"356444312.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210920"}]